GRh2 has been shown to counteract this resistance mechanism by suppressing lactylated METTL3, suggesting that GRh2 may serve as a potential inhibitor of lactylated METTL3 to ameliorate ATRA sensitivity in APL [64]. Here, METTL3 is linked to acute promyelocytic leukemia.